deaths (OS)progression or deaths (PFS)RFS/DFS

mBC - TNBC - L2 - all population breast cancer - triple negative mBC-Triple negative (TNBC) - 2nd Line (L2) mBC - TNBC - L2 - all population

versus Standard of Care (SoC)
olaparib vs. Standard of Care (SoC) 1 1.0better0.35.075 %1.0better0.35.0100 %-